Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise.
Dai WF, Craig E, Fraser B, Chambers A, Mai H, Brown MB, Earle CC, Evans WK, Geirnaert M, Taylor M, Trudeau M, Sperber D, Beca JM, Denburg A, Mercer RE, Parmar A, Tadrous M, Takhar P, Chan KKW, On Behalf Of The CanREValue Collaboration.
Dai WF, et al. Among authors: sperber d.
Curr Oncol. 2021 Nov 12;28(6):4645-4654. doi: 10.3390/curroncol28060392.
Curr Oncol. 2021.
PMID: 34898572
Free PMC article.